Supplemental material
Future Oncology
Volume 17, 2021 - Issue 19
Research Article
Real-World Data on Treatment Outcomes in EGFR-Mutant Non-Small-Cell Lung Cancer Patients Receiving Osimertinib in Second or Further Lines
Alessandro Dal Maso1 Oncology 2, Istituto Oncologico Veneto IOV – IRCCS, Padova, 35128, Italy;2 Department of Surgery, Oncology & Gastroenterology, University of Padova, Padova, 35128, Italy
https://orcid.org/0000-0003-3743-717X
https://orcid.org/0000-0003-3743-717X, , , Sara Pilotto3 Medical Oncology, University of Verona, AOUI Verona, Verona, 37126, Italyhttps://orcid.org/0000-0003-2229-4874
https://orcid.org/0000-0003-2229-4874, Fabiana Cecere4 Oncology 1, Regina Elena National Cancer Institute IRCCS Rome, Rome, 00144, Italyhttps://orcid.org/0000-0002-6881-6773
https://orcid.org/0000-0002-6881-6773, , , Alessandro Del Conte7 Medical Oncology & Immunorelated Tumors, Centro di Riferimento Oncologico (CRO) – IRCCS, Aviano(PN), 33081, Italyhttps://orcid.org/0000-0003-1763-0335
https://orcid.org/0000-0003-1763-0335, Giulia Sartori3 Medical Oncology, University of Verona, AOUI Verona, Verona, 37126, Italyhttps://orcid.org/0000-0002-3171-1396
https://orcid.org/0000-0002-3171-1396, , , Stefano Indraccolo2 Department of Surgery, Oncology & Gastroenterology, University of Padova, Padova, 35128, Italy;8 Immunology & Molecular Oncology Unit, Istituto Oncologico Veneto IOV – IRCCS, Padova, 35128, Italyhttps://orcid.org/0000-0002-4810-7136
https://orcid.org/0000-0002-4810-7136, Stefano Frega1 Oncology 2, Istituto Oncologico Veneto IOV – IRCCS, Padova, 35128, Italyhttps://orcid.org/0000-0002-2998-5072
https://orcid.org/0000-0002-2998-5072, Giovanna De Maglio9 Department of Pathology, Azienda Sanitaria Universitaria Friuli Centrale, Udine Hospital, Udine, 33100, Italyhttps://orcid.org/0000-0002-8884-3306
https://orcid.org/0000-0002-8884-3306, Jessica Menis1 Oncology 2, Istituto Oncologico Veneto IOV – IRCCS, Padova, 35128, Italy;2 Department of Surgery, Oncology & Gastroenterology, University of Padova, Padova, 35128, Italyhttps://orcid.org/0000-0001-5534-2874
https://orcid.org/0000-0001-5534-2874, Laura Bonanno1 Oncology 2, Istituto Oncologico Veneto IOV – IRCCS, Padova, 35128, Italyhttps://orcid.org/0000-0001-5218-4970
https://orcid.org/0000-0001-5218-4970, Fiorella Calabrese10 Pathology Unit, Department of Cardio-Thoracic & Vascular Sciences, University of Padova, Padova, 35128, Italyhttps://orcid.org/0000-0001-5351-9226
https://orcid.org/0000-0001-5351-9226, Valentina Guarneri1 Oncology 2, Istituto Oncologico Veneto IOV – IRCCS, Padova, 35128, Italy;2 Department of Surgery, Oncology & Gastroenterology, University of Padova, Padova, 35128, Italyhttps://orcid.org/0000-0002-2375-8397
https://orcid.org/0000-0002-2375-8397, PierFranco Conte1 Oncology 2, Istituto Oncologico Veneto IOV – IRCCS, Padova, 35128, Italy;2 Department of Surgery, Oncology & Gastroenterology, University of Padova, Padova, 35128, Italyhttps://orcid.org/0000-0002-5210-5344
https://orcid.org/0000-0002-5210-5344 & Giulia Pasello1 Oncology 2, Istituto Oncologico Veneto IOV – IRCCS, Padova, 35128, Italy;2 Department of Surgery, Oncology & Gastroenterology, University of Padova, Padova, 35128, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-8741-6038
https://orcid.org/0000-0002-8741-6038 show all